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Abstract
Background: Russian Republic of Karelia is located at the Russian-Finnish border. It contains most of the historical
Karelia land inhabited with autochthonous Karels and more recently migrated Russians. Although tuberculosis (TB)
incidence in Karelia is decreasing, it remains high (45.8/100 000 in 2014) with the rate of multi-drug resistance
(MDR) among newly diagnosed TB patients reaching 46.5 %. The study aimed to genetically characterize
Mycobacterium tuberculosis isolates obtained at different time points from TB patients from Karelia to gain insight
into the phylogeographic specificity of the circulating genotypes and to assess trends in evolution of drug resistant
subpopulations.
Methods: The sample included 150M. tuberculosis isolates: 78 isolated in 2013–2014 (“new” collection) and 72
isolated in 2006 (“old” collection). Drug susceptibility testing was done by the method of absolute concentrations.
DNA was subjected to spoligotyping and analysis of genotype-specific markers of the Latin-American-Mediterranean
(LAM) family and its sublineages and Beijing B0/W148-cluster.
Results: The largest spoligotypes were SIT1 (Beijing family, n = 42) and SIT40 (T family, n = 5). Beijing family was the
largest (n = 43) followed by T (n = 11), Ural (n = 10) and LAM (n = 8). Successful Russian clone, Beijing В0/W148, was
identified in 15 (34.9 %) of 43 Beijing isolates; all В0/W148 isolates were drug-resistant. Seven of 8 LAM isolates
belonged to the RD115/LAM-RUS branch, 1 - to the LAM RD174/RD-Rio sublineage. MDR was found in Beijing
(32/43), Ural (3/10), and LAM (3/8). In contrast, all T isolates were pansusceptible. Comparison of drug resistant
subgroups of the new and old collections showed an increasing prevalence of the B0/W148 clonal cluster, from
18.0 % (mainly polyresistant) in 2006 to 32.6 % in 2014 (mainly MDR and pre-XDR). The West–east increasing
gradient is observed for the Ural genotype that may be defined a ‘Russian’ strain. In contrast, the spoligotype SIT40
of the T family appears to be a historical Karelian strain.
Conclusions: Circulation of the MDR M. tuberculosis isolates of the Beijing genotype and its B0/W148 cluster
continues to critically influence the current situation with the MDR-TB control in northwestern Russia including the
Republic of Karelia. Revealed phylogeographic patterns of some genotypes reflect a complex demographic history
of Karelia within the course of the 20th century.
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Background
Tuberculosis (TB) in Russia remains a major national
health problem. However, one of the markers of an
unequal social and economic development of different
regions within the country is the disparity with regard to
the burden of TB. The Republic of Karelia is located at
the Russian-Finnish (de facto European Union) border
(800 km) and contains most of the historical Karelia
land. It occupies 180 520 sq. km and has a population of
632 533. Currently Karelia has high TB incidence of
45.8/100,000 in 2014 (although decreased from 62.3 in
2009) and very high level of mortality compared to the
Russian North-West as a whole (24 % higher in 2008)
[1, 2]. The situation is seriously aggravated by in-
crease in prevalence of multidrug-resistant (MDR)
Mycobacterium tuberculosis strains: from 15.4 % in
2006 to 46.5 % in 2014 in newly-diagnosed TB group
(two-fold higher than nationally) and from 64.1 % to
73.3 % among previously-treated patients (T. Sunchalina,
pers. comm.). Since the collapse of the USSR, the popula-
tion mobility via Finnish-Karelian border has been intensi-
fied [3, 4] which may have some impact on the
epidemiology of TB in Finland.
The study aimed to perform a molecular analysis of
M. tuberculosis isolates obtained at different time points
(2006 vs 2013–2014) from Karelian TB patients in order
to gain insight into the phylogeographic specificity of
the circulating genotypes and assess their role in spread
of drug resistant TB.
Methods
Bacterial strains
In total, 150M. tuberculosis isolates were analyzed.
Firstly, a “new” collection included 78 strains collected
prospectively from June 2013 to January 2014 in differ-
ent regions across Karelia. Of them, 69 were isolated
from newly diagnosed TB patients and constituted all
isolated from this patient category within the survey
period. Secondly, 71 strains (mainly drug-resistant) iso-
lated from newly diagnosed TB patients in 2006 made
up a retrospective convenience sample (“old” collection).
M. tuberculosis susceptibility to the first-line (isoniazid,
rifampicin, pyrazinamide, ethambutol, streptomycin) and
second-line (ofloxacin, cycloserine, amikacin, kanamycin,
capreomycin, ethionamide) anti-TB drugs was done
using a method of absolute concentrations [5] and/or
BACTEC MGIT 960 system according to the manufac-
turer’s recommendations. The bacteriology laboratory at
the Tuberculosis Dispensary in Petrozavodsk is externally
quality assured by the Federal System for External Quality
Assessment in Laboratory Medicine of Russian Federation.
The isolates were defined as multidrug-resistant (MDR), ex-
tremely drug resistant (XDR) and pre-XDR according to
the WHO definitions.
Ethical approval
The study was approved by Ethical Board of St. Petersburg
Research Institute of Phthisiopulmonology. All patients
gave informed written consent stating that they agree to
the anonymous use of their clinical and epidemio-
logical information and biological samples (DNA of
M. tuberculosis strain) for the study.
Genotyping
M. tuberculosis DNA was extracted using a recommended
method [6]. DNA was subjected to spoligotyping as
described [7]; spoligotyping profiles were compared to the
SITVIT_WEB database at http://www.pasteur-guadelou-
pe.fr:8081/SITVIT_ONLINE/query.
Latin-American Mediterranean (LAM) family was de-
tected by testing specific Rv0129c SNP; LAM isolates
were tested for RD115, RD174, RD-Rio, and LAM-RUS
markers using assays described previously [8–10].
Beijing B0/W148 cluster was identified by testing its spe-
cific Rv2664-Rv2665::IS6110 insertion [11]. MIRU26
VNTR locus was specifically tested on ambiguous Ural/
Haarlem spoligoprofiles; 1 copy in MIRU26 is considered
a marker of the Ural family [12]. Otherwise, Ural family
was identified by specific spoligotype signature [13].
A chi-square test was used to detect any significant
difference between the two groups. Yates corrected χ2
and P-values were calculated with 95 % confidence inter-
val at http://www.medcalc.org/calc/odds_ratio.php online
resource.
Results
Molecular characteristics of the new collection, 2013–2014
A total of 78M. tuberculosis isolates obtained from 2013
to 2014 represented patients from different districts
across Russian Karelia. All patients were permanent resi-
dents in Karelia, of Caucasian (“white”) ethnicity. Of
those 5 were homeless and the others had a registered
place of residency in urban or rural settings. Most of the
patients were newly diagnosed (n = 69), 9 were retreat-
ment cases. Fifty-six were male, 22 were female (which
makes a usual 2.5:1 gender ratio of TB). Mean age was
43.4 years (range: 22–87 years, SD ± 13.9), in male group
- 43.9 years (range: 22–87 years, SD ± 14.3), in female
group - 42.3 years (range: 28–82 years, SD ± 13.2).
To outline the population structure at M. tuberculosis
family/subfamily level, the isolates were subjected to the
combination of several molecular typing methods. Based
on spoligotyping, 78 isolates were subdivided into 8
types shared by 2 to 42 isolates and 16 singletons
(Table 1). Some types were not found in the published
version of the SITVIT database. Interestingly, the 2nd
largest type (after Beijing SIT1, 42 isolates) was SIT40
(T family) that included 5 isolates.
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Based on spoligotyping and other molecular markers,
78 isolates were assigned to the following families:
Beijing (n = 43), “ill-defined” T family (n = 11), Ural (n =
10), LAM (n = 8), Haarlem (n = 4), X (n = 1), and un-
known family (n = 1) (Table 2). Of 43 Beijing isolates, 14
belonged to the B0/W148-cluster previously termed as
Russian successful clone [11]. Interestingly, Ural sample
was small enough but quite diverse even at the level of
spoligotyping: 10 isolates presented 6 different profiles.
LAM family included 7 isolates of RD115 sublineage (all
belonged to its LAM-RUS branch) and 1 isolate of
RD174/RD-Rio sublineage (a SIT20 isolate).
Thirty-two isolates were susceptible to all tested drugs,
6 isolates were monoresistant (of them 5 were STR-
resistant) and 41 isolates were resistant to two and more
drugs. The resistant isolates were subdivided into MDR,
pre-XDR and XDR groups and stratified by genetic fam-
ily (Table 1, Table 2). The Beijing family was associated
with the high rate of drug resistance: 32 of 43 Beijing
family strains were MDR (this includes also pre-XDR
Table 2 Distribution of drug resistance across M. tuberculosis families, 2013–2014
Family, clustera All Sensitive MDRb Pre-XDR XDR Poly/monores.
Beijing 43 7 32 14 5 4
B0/W148-cluster 15 14 6 2 1
Other Beijing 28 7 18 8 3 3
T 11 11
Ural 10 7 3 1
LAM 8 4 3 1 1 1
LAM-RUS 7 3 3 1 1 1
Haarlem 4 2 1 1
aSingle isolates were of X (sensitive) and unknown family (MDR) and are not shown
bMDR includes also pre-XDR and XDR
Table 1 Spoligotypes and drug resistance profiles of M. tuberculosis isolates, 2013-2014
aFamily assigned by SITVIT_WEB and corrected by use of other markers. SIT20 is RD-Rio, other LAM SIT are LAM-RUS
bMDR includes also pre-XDR and XDR
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and XDR isolates). Multidrug resistance was also found
in the LAM (3 of 8 isolates) and the Ural (3 of 10) geno-
types. In contrast, all 11 isolates of the T family were
sensitive to all tested drugs. One should note that the
Beijing B0/W148 variant included only drug resistant
isolates (8 of 15 were pre-XDR or XDR) while the other
Beijing variants (n = 28) included 11 pre-XDR/XDR and
7 sensitive isolates.
Within the new collection the MDR rate among all ge-
notypes (Table 2) shows an association with MDR for
Beijing family (32/43 vs 7/35 other genotypes pooled to-
gether; P < 0.0001). Data on resistance to the second-line
drugs also show an association between the Beijing family
and pre-XDR and XDR profile: 19/43 Beijing family vs 3/
35 other genotypes’ isolates, P = 0.0016).
Molecular characteristics of the retrospective collection,
2006
The available retrospective collection of 71 strains
isolated in 2006 presented a convenience sample that
included mostly drug resistant isolates (60 isolates
were resistant and 11 were susceptible). Within this
study, it was used to assess changes in the epidemiology of
drug resistant subpopulation of M. tuberculosis in Karelia
when compared with new collection described above.
Two patients were homeless while the rest had a regis-
tered place of residence. Fifty-two patients were male, 19
were female. Mean age was 43.0 years (range: 21–72
years, SD ± 12.5); in the male group - 42.7 years (range:
21–72 years, SD ± 11.7), in the female group - 43.9 years
(range: 24–72 years, SD ± 14.8).
The isolates were subjected to the same typing meth-
odology as described above for the new collection. The
distribution of genotypes within the entire collection
and across different drug resistance categories is shown
in Tables 3 and 4. The Beijing family was represented by
a single spoligotype SIT1 (67.6 % of the entire collec-
tion). It was followed by more diverse LAM (12 isolates,
7 profiles) and T (5 isolates, 5 profiles) families. Most
profiles received SIT numbers through comparison with
SITVIT_WEB while 4 profiles were not found in this
database.
Almost one-fourth of the Beijing isolates belonged to
the B0/W148 cluster. All LAM isolates belonged to the
RD115 sublineage and its LAM-RUS branch.
Multi-drug resistance was identified only in the isolates
that belonged to the Beijing and LAM families (Table 4).
Majority of the Beijing (31/48) and half of the LAM family
strains were MDR. In case of the LAM family, MDR was
not associated with any particular spoligotype. Although
XDR was not identified in any of those isolates, 17 of 48
Beijing and 3 of 12 LAM were pre-XDR.
Comparison of drug resistant subpopulations from two
time periods
A retrospective collection of 72 strains isolated in
2006 was mainly drug resistant and we looked at the
two time points separately for drug resistant (60 vs
Table 3 Spoligotypes and drug resistance profiles of M. tuberculosis isolates, 2006
aFamily was assigned by SITVIT_WEB and corrected by use of other markers
bMDR includes also pre-XDR
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46 isolates) and susceptible (11 vs. 32 isolates) sub-
groups (Tables 2 and 4).
Quantitative and qualitative trends observed in drug
resistant subgroups, from 2006 to 2014, show some in-
crease in the prevalence of the Beijing genotype from
73.8 % (45/61) to 78.3 % (36/46). However a closer look
reveals that this increase was exclusively due to the in-
creasing rate of the B0/W148 clonal cluster, from 18.0 %
(mainly polyresistant) to 32.6 % (mainly MDR and pre-
XDR), although borderline non-significantly (P = 0.08).
The B0/W148 strains were absent in fully susceptible
groups from both collections. The prevalence of other,
non-B0 Beijing strains was similar within the resistant
groups: 39.3 % (24/61) and 39.1 % (18/46) in 2006 and
2014, respectively.
A comparison of drug susceptible subgroups from the
2006 and 2014 collections showed that T-family isolates
did not acquire additional resistance; its prevalence was
similar among susceptible isolates (3/11 in 2006 and 11/
32 in 2014). However this observation should be inter-
preted with caution due to the lack of clarity in defin-
ition of the T family as a whole.
Discussion
Epidemiology of tuberculosis in a given area is greatly in-
fluenced by social and economic situation, health policy as
a whole and implementation of National program against
TB in particular. No less it is defined by the local popula-
tion structure of the circulating M. tuberculosis strains: an
increasing prevalence of highly virulent clones may severely
jeopardize efforts of health authorities. Two collections of
strains collected with 8-year gap, were used to perform a
phylogeographic analysis in the context of neighboring
countries and Russian provinces and in the light of human
migration and changing demographics, and to assess mo-
lecular epidemiology and dynamic changes of the drug re-
sistant M. tuberculosis subpopulations in Karelia.
Phylogeography
Past migration of human populations in this area in
Northern Europe and historically more recent trans-border
exchange shaped both human and human pathogens’ local
population structures. In modern Karelia the proportion of
Karels (autochthonous people close to Finns) decreased
from 37.4 % in 1926 to 7.4 % in 2010. This occurred
through massive influx from the neighboring Russian re-
gions between 1920s and 1940 and from more distant and
diverse areas across the USSR in 1946–1954 [14]. Further-
more, the borders and population of the Soviet
Republic of Karelia have undergone changes since 1920s
through (i) incorporation of the ethnically Russian
districts, and (ii) annexation of parts of Finnish Karelia by
the Soviet Union in 1940/1944 [15, 16].
Distribution of genetic families across historic re-
gions within Karelia is shown on the map (Fig. 1), it
was also compared to the neighboring areas (Fig. 2;
Tables 5 and 6) [11, 17–27] although different study
design was a limitation.
Beijing and LAM families are found prevalent in all
Karelian regions (except for Pudozh and Ladoga but this
data may be biased by small sample sizes). Beijing
genotype is prevalent among M. tuberculosis strains
circulating in Karelia but its prevalence in Finland
remains low in spite of close trans-border contacts
between Finland and St. Petersburg and Karelia. Fur-
thermore, Beijing genotype isolates in Finland are likely
not to be associated with Russian contact but rather with
an increasing immigration from Asia [17, 28]. We observe
similar and low prevalence rates of LAM family in Finland
and adjacent Russian Karelia and Murmansk that is lower
than in St. Petersburg and Pskov.
While Beijing and LAM present two the most preva-
lent families of M. tuberculosis across Russia, the Ural
family was suggested as both endemic and low-prevalent
lineage in Northern Eurasia (~ Former Soviet Union)
(13). As far as this study is concerned, the rate of the
Ural family appears to decrease in Finland vs Karelia.
Furthermore, within Karelia the West–east increasing
gradient of the Ural genotype is observed with the high-
est rate in the southeast (Fig. 1). Notably, half of the Ural
family strains were isolated in a single south-easternmost
Pudozh district. It should be noted that even in the early
Table 4 Drug resistant and susceptible M. tuberculosis isolates, 2006
Family, cluster All Sensitive MDRa Pre-XDR Poly/monores.
Beijing, n = 48 48 3 31 17 14
B0/W148-cluster, n = 11 11 4 3 7
Other Beijing, n = 37 37 3 27 14 7
T, n = 5 5 3 2
Ural , n = 2 2 1 1
LAM, n = 12 12 1 6 3 5
X, n = 1 1 1
Unknown, n = 3 3 3
aMDR includes also pre-XDR
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1920s (when proportion of Karels in Russian Autonomous
Republic of Karelia was relatively high, 40 %); the popula-
tion of this district was almost 100 % Russian [29]. In this
regard, the Ural family may justly be regarded as a
“Russian” strain brought to Karelia through relatively
long-term human influx from Russia.
In contrast to the Ural family, SIT40, the largest non-
Beijing type, appears to be a historical Karelian strain
which distribution is marked with decreasing rate both
to the West (Finland and Sweden) and East/North
(Archangel and Murmansk) of Karelia. SIT40 is rare
elsewhere on a global scale (n = 112, according to
SITVIT_WEB), it is found on different continents, but
mainly in Europe (Italy, Austria, Germany, Denmark,
Netherlands, USA, at 0.2–0.7 %). Among Northern
neighbors of Karelia it is found in a very low percent in
Finland, Sweden and in the northern Russian regions of
Murmansk and Archangel to the North and East of
Karelia (Table 5). Interestingly, we found one SIT40 iso-
late (STR-INH-resistant) in the 2006, mainly drug-
resistant collection in Karelia, Olonets region (Pryazha
district) in a newly diagnosed elderly patient born in
1942. This is the same area, namely, southern Karelia,
where most of the SIT40 isolates were detected by
Fig. 1 Distribution of M. tuberculosis genotypes (collection 2013–2014) in different regions of Karelia Circle size is roughly proportional to the
sample size. Ptz = Petrozavodsk. Free map: http://commons.wikimedia.org/wiki/File:Karelia_today.png
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the current study. Noteworthy, Karels constitute 37 %
of population in the Pryazha district (compared to
7.5 % in all Russian Republic of Karelia) and the rate
of rural, less mobile population is as high as 74 %
[30]. In view of the above, we speculate that SIT40
may present a historical clone in the Karelia area in
northern Europe. Based on the whole genome (new
generation) sequencing of one SIT40 strain, it was
assigned to the Euro-American lineage and SNP-barcode
4.1 according to Coll et al. [31] (Igor Mokrousov,
Ekaterina Chernyaeva, Anna Vyazovaya, unpublished
observations).
Finally, we feel that a minor note should be added
about one particular spoligotype identified in one
LAM strain in the new collection. It is SIT266 highly
prevalent in Belarus [10, 32, 33] that is not a neighbor
of Karelia. Interestingly, the proportion of Belarusians
increased in Karelia from 0.9 % in 1939 to 10.9 % in
Fig. 2 Distribution of M. tuberculosis genotypes in Karelia (collection 2013–2014) in its neighboring regions in Russia, and in Finland. Circle size is not
proportional to the sample size. The same color coding is used as in Fig 1, but Beijing genotype is shown by a single yellow color, without separate
shading of the Beijing B0/W148 variant. Free map: http://s8366.chomikuj.pl/ChomikImage.aspx?e=6c-SLnsUnfRfdfr7pJzD_Ks6q2jz1mmsSXERXBmYqw0
C3H5OBm9Si_yGn7ckP54SV8PouVOQiyMi4FM5truhxxxGI_tRJhzFlrimtfVsbns&pv=2
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Table 5 Spoligotypes identified in this study (2013–2014 sample) and in neighboring areas, %
aFamily assigned by SITVIT_WEB and corrected by use of other markers. SIT20 is RD-Rio, other LAM SIT are LAM-RUS
Previously published collections represent: Finland (Finnish-born [17]), Estonia (old sample - 2000 and earlier [23]), Latvia (old sample and mainly drug resistant
[27]), Sweden (patients born before 1945 [21]), Pskov, Russia [18], Murmansk, Russia [24], Tula, Russia (prison setting [22]), Moscow, Russia (mainly MDR [19]),
Archangel, Russia (prison setting [26])
Table 6 Distribution of genotype families identified in M. tuberculosis in Karelia (2013–2014 sample) in its neighbors (% of total population)
Family, cluster Kareliaa, this study,
year 2014, n = 78




Beijing 55.1 51 44.4 50 1.5 15.2
B0/W148-cluster 19.2 13 8 5.5 (MDR sample)
Other Beijing 35.9 38 37 44.5 (MDR sample)
T 14.1 4–8 (ca 6) 14 13.7 36.6 23.9
Ural 12.8 6.5 5.6 13.6 6.8 2.3
LAM 10.3 25 25 8 8.9 3.8
LAM-RUS 9.0 24 25
Haarlem 5.1 4–8 (ca 6) 11 7.3 29.2 7.6
Other 2.6 5 0 7.4 17 47.2
aKarelia: Single isolates (X and unknown) are not shown
Settings (references): Pskov [18]; St. Petersburg [11, 20, 25]; Murmansk [24], Finland [17]
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1959. Although many Belarusians returned to their
home country in the 1960s [14, 34], it could be that an
isolate of the “Belarusian” genotype SIT266 may repre-
sent a heritage of that past event 50 years ago.
Drug resistance
Our results on drug resistance rates are in line with earl-
ier studies carried out in different parts of the former
Soviet Union that have demonstrated an association of
the Beijing genotype with MDR and a continuously in-
creasing rate of MDR among Beijing strains. In north-
western Russia, the MDR rate among Beijing strains
from new TB cases was 79.8 % in Murmansk [24],
64.5 % in Kaliningrad [35], 79.3 % in Pskov [18]. In other
parts of Russia it was somewhat lower, 46.9 % in Ural
[36] and 34 % in Siberia [37]. With further evolution of
the TB epidemic in Russia, the MDR phenotype is evolv-
ing to XDR, and consequently, this association is re-
peated for XDR [38, 39]. One can hardly expect an
improvement of the situation in the country in view of
the (i) unchanged M. tuberculosis population structure
with increasing prevalence of the drug resistant variants
and (ii) unchanged (insufficient) TB control measures.
A closer look inside the Beijing family revealed a special
role of the cluster named B0/W148 and termed a “success-
ful Russian clone” [11]. The increasing active circulation of
this Beijing variant appears to be one of the major causes
behind increasing rate of MDR-TB in Karelia in the last
8 years. Indeed a meta-analysis of different studies across
the Former Soviet Union demonstrated highest propensity
of B0/W148 to acquire drug resistance even when com-
pared to the other Beijing variants [11]. A recent spinal TB
study also highlighted a crucial capacity of the Beijing B0/
W148 strains to disseminate to other sites [40].
On the other hand, drug susceptible group was and re-
mains to be dominated by non-Beijing genotypes. In this
regard, an intriguing decrease of the prevalence of the
LAM family within the drug resistant group from 18.0 %
(11/61) in 2006 to 8.7 % (4/46) in 2014 (P = 0.2) may be
noted. This result looks unusual since the LAM family
was demonstrated to be associated with drug resistance
in other parts of Russia [18, 22].
Finally, the Ural family has been considered a low-
virulent genotype of M. tuberculosis (reviewed in
Mokrousov [41]) and is at low rate in Karelia. How-
ever even for the Ural genotype, similarly to the
Beijing genotype, we observe both quantitative and
qualitative worrisome changes: 1 polyresistant isolate
(out of 61 drug resistant) in 2006 versus 3 MDR iso-
lates (out of 46) in 2014. Again, this observation is in
line with recent alarming trends in evolution of this
“less exciting” family of M. tuberculosis. While meta-
analysis showed a lack of association with drug resist-
ance of these strains in the former USSR [13], very
recent reports from different countries in Eastern
Europe with apparently different National TB control
programs describe an emergence of the MDR Ural
strains [40, 42].
Conclusions
Despite decreasing incidence of TB in Karelia in the last
years, the situation with drug resistant TB continues to
worsen. The most hazardous strains and clones (Beijing
B0/W148 cluster being the major threat) furthermore
dominated by MDR and pre-XDR isolates, increasingly
spread within the population. Contrasting phylogeo-
graphic patterns have been revealed for the Ural
genotype and SIT40 spoligotype; they may reflect a
complex demographic history of Karelia within the
course of the 20th century.
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